These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8027974)

  • 1. Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines.
    Glennon RA; Dukat M; el-Bermawy M; Law H; De los Angeles J; Teitler M; King A; Herrick-Davis K
    J Med Chem; 1994 Jun; 37(13):1929-35. PubMed ID: 8027974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and serotonin receptor affinities of a series of trans-2-(indol-3-yl)cyclopropylamine derivatives.
    Vangveravong S; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1998 Dec; 41(25):4995-5001. PubMed ID: 9836617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.
    Lyon RA; Titeler M; Seggel MR; Glennon RA
    Eur J Pharmacol; 1988 Jan; 145(3):291-7. PubMed ID: 3350047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of indolylalkylamines at 5-HT2 serotonin receptors: examination of a hydrophobic binding region.
    Glennon RA; Chaurasia C; Titeler M
    J Med Chem; 1990 Oct; 33(10):2777-84. PubMed ID: 2213830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin analogues: the effect of structural modification on 5-HT2 serotonin receptor binding.
    Ismaiel AM; Arruda K; Teitler M; Glennon RA
    J Med Chem; 1995 Mar; 38(7):1196-202. PubMed ID: 7707322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
    Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
    Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
    Nichols DE; Frescas S; Marona-Lewicka D; Huang X; Roth BL; Gudelsky GA; Nash JF
    J Med Chem; 1994 Dec; 37(25):4346-51. PubMed ID: 7996545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Serotoninergic Ligands Containing Indolic and Methyl Indolic Nuclei: Synthesis and In Vitro Pharmacological Evaluation.
    Magli E; Severino B; Corvino A; Perissutti E; Frecentese F; Saccone I; Giordano F; Castro M; Brea J; Loza MI; Santagada V; Caliendo G; Fiorino F
    Med Chem; 2020; 16(4):517-530. PubMed ID: 31203804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
    Westkaemper RB; Runyon SP; Bondarev ML; Savage JE; Roth BL; Glennon RA
    Eur J Pharmacol; 1999 Sep; 380(1):R5-7. PubMed ID: 10513561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.
    Hansen M; Phonekeo K; Paine JS; Leth-Petersen S; Begtrup M; Bräuner-Osborne H; Kristensen JL
    ACS Chem Neurosci; 2014 Mar; 5(3):243-9. PubMed ID: 24397362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mianserin-induced down-regulation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors stably expressed in the human neuroblastoma cell line SH-SY5Y.
    Newton RA; Elliott JM
    J Neurochem; 1997 Sep; 69(3):1031-8. PubMed ID: 9282925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes.
    Nishio H; Inoue A; Nakata Y
    Arch Int Pharmacodyn Ther; 1996; 331(2):189-202. PubMed ID: 8937629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs.
    Kuoppamäki M; Pälvimäki EP; Hietala J; Syvälahti E
    Neuropsychopharmacology; 1995 Oct; 13(2):139-50. PubMed ID: 8597525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
    Wolf WA; Schutz LJ
    J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.